Navidea Biopharmaceuticals (NAVB) Competitors $0.0005 +0.00 (+25.00%) As of 09:49 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOptions ChainSEC FilingsTrendsBuy This Stock NAVB vs. HSTO, VAXX, HEPA, SMFL, SCPS, EVLO, CMRA, GNCAQ, GNCA, and ARDSShould you be buying Navidea Biopharmaceuticals stock or one of its competitors? The main competitors of Navidea Biopharmaceuticals include Histogen (HSTO), Vaxxinity (VAXX), Hepion Pharmaceuticals (HEPA), Smart for Life (SMFL), Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), and Aridis Pharmaceuticals (ARDS). These companies are all part of the "pharmaceutical products" industry. Navidea Biopharmaceuticals vs. Histogen Vaxxinity Hepion Pharmaceuticals Smart for Life Scopus BioPharma Evelo Biosciences Comera Life Sciences Genocea Biosciences Genocea Biosciences Aridis Pharmaceuticals Histogen (NASDAQ:HSTO) and Navidea Biopharmaceuticals (NYSE:NAVB) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk. Which has more volatility and risk, HSTO or NAVB? Histogen has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Comparatively, Navidea Biopharmaceuticals has a beta of 1.87, meaning that its stock price is 87% more volatile than the S&P 500. Do institutionals and insiders hold more shares of HSTO or NAVB? 0.0% of Navidea Biopharmaceuticals shares are owned by institutional investors. 3.3% of Histogen shares are owned by company insiders. Comparatively, 43.7% of Navidea Biopharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community believe in HSTO or NAVB? Histogen received 7 more outperform votes than Navidea Biopharmaceuticals when rated by MarketBeat users. Likewise, 58.33% of users gave Histogen an outperform vote while only 0.00% of users gave Navidea Biopharmaceuticals an outperform vote. CompanyUnderperformOutperformHistogenOutperform Votes758.33% Underperform Votes541.67% Navidea BiopharmaceuticalsOutperform VotesNo VotesUnderperform Votes81100.00% Is HSTO or NAVB more profitable? Company Net Margins Return on Equity Return on Assets HistogenN/A N/A N/A Navidea Biopharmaceuticals N/A N/A N/A Does the media prefer HSTO or NAVB? In the previous week, Navidea Biopharmaceuticals had 2 more articles in the media than Histogen. MarketBeat recorded 2 mentions for Navidea Biopharmaceuticals and 0 mentions for Histogen. Histogen's average media sentiment score of 0.00 equaled Navidea Biopharmaceuticals'average media sentiment score. Company Overall Sentiment Histogen Neutral Navidea Biopharmaceuticals Neutral Which has better valuation & earnings, HSTO or NAVB? Histogen has higher revenue and earnings than Navidea Biopharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHistogen$19K6.29-$10.62M-$2.81-0.01Navidea Biopharmaceuticals$8.13K6.16-$15.18MN/AN/A SummaryHistogen beats Navidea Biopharmaceuticals on 5 of the 9 factors compared between the two stocks. Remove Ads Get Navidea Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAVB vs. The Competition Export to ExcelMetricNavidea BiopharmaceuticalsDiagnostic substances IndustryMedical SectorNYSE ExchangeMarket Cap$50,000.00$2.45B$5.58B$19.64BDividend YieldN/A0.74%5.35%3.77%P/E RatioN/A6.2423.1233.46Price / Sales6.1642.89369.1926.71Price / CashN/A15.7538.1617.54Price / BookN/A2.996.704.61Net Income-$15.18M-$65.73M$3.20B$1.02B7 Day PerformanceN/A-2.47%-4.00%-0.86%1 Month PerformanceN/A-12.52%-0.64%-3.14%1 Year PerformanceN/A-23.48%9.09%5.48% Navidea Biopharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAVBNavidea BiopharmaceuticalsN/A$0.00+25.0%N/A-98.9%$50,000.00$8,126.000.0010Analyst ForecastNews CoverageGap UpHSTOHistogenN/A$0.03flatN/A-92.2%$120,000.00$19,000.00-0.0120VAXXVaxxinityN/A$0.00-88.0%N/A-93.0%$76,000.00N/A0.0090Upcoming EarningsHEPAHepion Pharmaceuticals0.7657 of 5 stars$0.43-10.4%N/A-99.6%$60,000.00N/A-0.1020Positive NewsGap DownHigh Trading VolumeSMFLSmart for LifeN/A$0.00-3.7%N/A-99.9%$18,000.00$11.11M0.00110Gap DownSCPSScopus BioPharmaN/A$0.00flatN/AN/A$13,000.00N/A0.009EVLOEvelo BiosciencesN/A$0.00flatN/A-99.0%$9,000.00N/A0.00120CMRAComera Life SciencesN/A$0.00flatN/AN/A$6,000.00$1.00M0.002GNCAQGenocea BiosciencesN/AN/AN/AN/A$6,000.00N/A0.0070Gap UpGNCAGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.91M0.0070ARDSAridis PharmaceuticalsN/A$0.00flatN/A-99.9%$5,000.00$3.09M0.0030 Remove Ads Related Companies and Tools Related Companies Histogen Competitors Vaxxinity Competitors Hepion Pharmaceuticals Competitors Smart for Life Competitors Scopus BioPharma Competitors Evelo Biosciences Competitors Comera Life Sciences Competitors Genocea Biosciences Competitors Genocea Biosciences Competitors Aridis Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NAVB) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredTrump’s betrayal exposed Fair warning: this will not make for easy viewing. Especially if you voted for Trump, put your faith in hi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Navidea Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Navidea Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NAVB Stock Free NAVB Stock Alerts